Figure INF-6. HCV antibody prevalence among injecting drug users: studies with national and sub-national coverage.

Part (i) All injecting drug users, 2010–11

Country	year	National		Sub-national
Related links:
Czech Republic	2011	18.2
Hungary	2011	24.1		23.8	9.9	34.2	31.2
Slovenia	2011	28.5
Malta	2011	34.4
Slovakia	2011			40.3
Austria	2011	48.5	34.2	69.6	67.1	38.6
United Kingdom^	2011	43.0		44.5	28.7	53.2
Turkey	2011	48.6
Cyprus	2011	52.6
Sweden	2010			55.7
Portugal***	2010/2011	79.7	36.5
Netherlands^^	2010/2011			50.0	67.4
Italy*	2010	60.5		67.5	58.9	43.5	34.5	65.1	46.3	63.4	55.5	79.8	56.9	65.1	61.9	69.1	64.5	68.5	80.5
Latvia**	2010/2011			81.5	58.9	52.4	50.0
Belgium	2011			81.5	42.3
Germany	2011			56.0	71.6
Norway	2011	65.0		63.3
Greece	2011	69.4	62.4	79.3	76.5	67.5	61.7	35.0	67.4	71.7	52.6	36.4	33	59.6	70	61	60.5
Bulgaria	2011			67.8
Estonia	2010			76.0
Poland
Finland
Romania
Denmark
Croatia
Luxembourg
Lithuania
France
Ireland
Spain
https://www.emcdda.europa.eu/stats13/inffig6a
For primary sources, study details and data before 2010, see INF-111 and INF-0
See also 'General notes for interpreting data' on the Explanatory notes and help page

Notes:

Black squares are samples with national coverage; blue triangles are samples with sub-national (including local or regional) coverage. Differences between countries have to be interpreted with caution owing to different types of settings and/or study methods; national sampling strategies vary.

Countries are presented by order of increasing prevalence, based on the average of national data or, if not available, of sub-national data.

Sources:

Reitox Network

Country	Czech Republic	Hungary	Slovenia	Malta	Slovakia	Austria	United Kingdom^	Turkey	Cyprus	Sweden	Portugal***	Netherlands^^	Italy*	Latvia**	Belgium	Germany	Norway	Greece	Bulgaria	Estonia
National	18.2	24.1	28.5	34.4		48.5	43.0	48.6	52.6		79.7		60.5				65.0	69.4
National						34.2					36.5							62.4

Subnational		23.8			40.3	69.6	44.5			55.7		50.0	67.5	81.5	81.5	56.0	63.3	79.3	67.8	76.0
Subnational		9.9				67.1	28.7					67.4	58.9	58.9	42.3	71.6		76.5
Subnational		34.2				38.6	53.2						43.5	52.4				67.5
Subnational		31.2											34.5	50.0				61.7
Subnational													65.1					35.0
Subnational													46.3					67.4
Subnational													63.4					71.7
Subnational													55.5					52.6
Subnational													79.8					36.4
Subnational													56.9					33.3
Subnational													65.1					59.6
Subnational													61.9					70.3
Subnational													69.1					60.6
Subnational													64.5					60.5
Subnational													68.5
Subnational													80.5

inffig6a

Demonstration	Reference	Type	Y Axis	X axis	Label	Width (%)	Height (px)	Y plotline	Y min,max values	series Markers
	szrfig1	column,column,line	Quantity (kg)\|Number of seizures$3
	szrfig2	column,column,line	Quantity (kg)\|Number of seizures$3
	gpsfig4a	line	%				500		0,30
	gpsfig1	column	%				500		0,25
	gpsfig2	column,column,point	Contiuation rates %\|LTP all adults$3						0,
	gpsfig18a	distribution	Estimated prevalence (%)						0
	gpsfig18b	distribution	Estimated prevalence (%)						0
	gpsfig20	column	%				600		0,20
	dlofig2	stackedBar	%				600
	dlofig3	line	Index (2006 = 100)			68
	dlofig3$	pie			1 135 701 reports (2011)	30
	dlofig4	line	Index (2006 = 100)			68
	dlofig4$	pie			915 541 reports (2011)	30
	dlofig5	line	Index (2006 = 100)			68
	dlofig5$	pie			179 418 reports (2011)	30
	drdfig12a	scatter	Ratio between DRD in 2003 and 2000	Number of DRD in 2000				1
	drdfig12b	scatter	Ratio between DRD in 2010/11 and 2003	Number of DRD in 2003				1
	hsrfig2	stackedColumn	Clients in substitution treatment
	dlofig1	line	Index (2006 = 100)						60,180
	drdfig1	column	Country and total number of DRD				600
	drdfig2	column	Proportion of DRD under the age of 25 (%)				600
	drdfig3	line	Mean age in years
	drdfig4	line	Mean age in years
	drdfig5a	line	Index (1990 = 100)
	drdfig5b	line	Index (1996 = 100)
	drdfig6	line	Index (1990 = 100 %)						80,160
	drdfig7a	column	Mortality rate per million
	drdfig7b	column,point	Rate per million
	drdfig8	line	Index (1985 = 100 %)						50,650
	drdfig9a	line	%						0,70
	drdfig9b	line	%
	drdfig9c	line	%
	drdfig10	column	Mean age in years				500
	drdfig11a	line	Index						0,300
	drdfig11b	line	Index
	drdfig11c	line	Index
	drdfig13a	line	Number of cases
	drdfig13b	line	Number of cases
	eyefig1a	line
	eyefig1b	line
	eyefig1c	line							0,
	eyefig1d	line	%			45	800
	eyefig1d$	line	%			45	800
	gpsfig3	column	%				500
	gpsfig4b	line	%
	gpsfig5	column	%
	gpsfig6	column	%
	gpsfig7	column	%
	gpsfig8a	line	%						0,
	gpsfig8b	line	%						0,
	gpsfig9a	column	%
	gpsfig9b	column	%
	gpsfig10	line	%
	gpsfig11	column,column,point	Continuation rates (%)\| LTP All adults$3
	gpsfig12a	line	%						0,
	gpsfig12b	line	%						0,
	gpsfig13	column,column,point	%
	gpsfig14a	line	%						0,
	gpsfig14b	line	%						0,
	gpsfig15	column	%
	gpsfig16	column,column,point	Continuation rates (%)\|LTP All adults$3						0,
	gpsfig17	column	%
	gpsfig21a	line	%						0,
	gpsfig21b	line	%						0,
	gpsfig22	column,column,point	Continuation rates (%)\| LTP All adults$3
	gpsfig23a	line	%
	gpsfig23b	line	%
	gpsfig23c	line	%
	gpsfig23d	line	%						0,
	gpsfig23e	line	%						0,
	hsrfig4	pie			% of prison population in OST	30
	inffig1a	line	New AIDS cases per million population				700		0,
	inffig1b	line	New AIDS cases per million population				700		0,
	inffig2a	line	Cases per million population						0,
	inffig2b	line	Cases per million population						0,
	inffig2c	line	Cases per million population
	inffig2d	line	Cases per million population
	inffig3a	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig3b	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig3c	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig6a	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig6b	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig6c	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig9a	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	inffig9b	distribution	%						0,	National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)
	pppfig1	line	Index (2005 = 100)
	pppfig2	line	Index (2005 = 100)
	tdifig1a	line	%
	tdifig1b	line
	tdifig2a	pie				30
	tdifig2b	pie				50
	tdifig3a	line	%
	tdifig3b	line
	tdifig7	line	%			60			0,
	tdifig7$	stackedColumn	Numbers			38			0,50000
	hsrfig1b	stackedColumn	%































Distirbuted points with specific markers and colours	inffig6a	distribution	%							National;Subnational\|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8)

Download spreadsheet version (.xls)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Quick links

Page last updated: Wednesday, 27 November 2013